| Alzheimer Disease |
1 |
1 |
| Food and Drug Administration (FDA) |
0 |
0.98 |
| Aducanumab |
0 |
0.95 |
| Amyloid Plaque |
0 |
0.4 |
| Brain |
0 |
0.14 |
| Central Nervous System |
0 |
0.07 |
| Drug Development |
0 |
0.3 |
| Grant |
0 |
0.07 |
| Health Care Quality, Access, and Evaluation |
0 |
0.07 |
| Social Determinants of Health |
0 |
0.07 |